drugset
drugset / Trial / NCT00184639

Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes

NCT00184639 ↗

Phase 3 Completed 71 enrolled Novo Nordisk A/S
RandomizedCrossoverOpen-labelTreatment

Summary

This trial is conducted in Europe. A 32-week efficacy and safety comparison of insulin detemir and insulin semilente MC in children between 6 and 21 years with type 1 diabetes.

Timeline

Start
2004-08-16
Primary completion
2005-11-22
Completion
2005-11-22

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin detemir Protein / enzyme biologic — —

Indications

type 1 diabetes mellitus